How Does Health Technology Assessment of Personalized Medicine for Non-Small Cell Lung Cancer Differ in France, Germany, and England?

Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.2367
https://www.valueinhealthjournal.com/article/S1098-3015(16)33733-0/fulltext
Title : How Does Health Technology Assessment of Personalized Medicine for Non-Small Cell Lung Cancer Differ in France, Germany, and England?
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33733-0&doi=10.1016/j.jval.2016.09.2367
First page : A761
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 2247
Categories :
Tags :
Regions :
ViH Article Tags :